Cancer genetics

Updated protocols

The following protocols have received important updates in the past 90 days:

• Endocrine cancer and tumours – referring to genetics
• Mismatch repair (MMR) – genetic testing
• APC – genetic testing
• RET (MEN2) – genetic testing
• APC (Familial adenomatous polyposis) – risk management
• MMR genes (Lynch syndrome) – risk management
• Facts for people and families with Familial Adenomatous Polyposis
• Facts for people and families with Multiple Endocrine Neoplasia type 2
• Facts for people and families with a faulty MLH1 gene (Lynch syndrome)
• Facts for people and families with a faulty MSH2 gene (Lynch syndrome)
• Facts for people and families with a faulty MSH6 gene (Lynch syndrome)
• CDC73 – genetic testing
• CDC73 (Hyperparathyroidism-jaw tumour syndrome) – risk management
• Facts for people and families with Hyperparathyroidism-jaw tumour (HPT-JT) syndrome